Blood pressure response to estrogen-progestin oral contraceptive after pregnancy-induced hypertension.
D001794:Blood Pressure / Q000187:drug effects*; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects*; D004338:Drug Combinations; D004461:Eclampsia / Q000503:physiopathology; D045166:Estradiol Congeners / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000139:chemically induced* / Q000503:physiopathology*; D008656:Mestranol / Q000009:adverse effects; D009640:Norethindrone / Q000009:adverse effects; D010298:Parity; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000503:physiopathology*; D045167:Progesterone Congeners / Q000009:adverse effects*; D012306:Risk
D003276:Contraceptives, Oral; D003280:Contraceptives, Oral, Synthetic; D004338:Drug Combinations; D045166:Estradiol Congeners; D045167:Progesterone Congeners; D008656:Mestranol; D009640:Norethindrone